Rethinking stroke prevention for asymptomatic carotid illness

This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://www.ama-assn.org/public-health/chronic-diseases/rethinking-stroke-prevention-asymptomatic-carotid-disease
and if you wish to take away this text from our web site please contact us


AMA News Wire

Rethinking stroke prevention for asymptomatic carotid illness

Feb 25, 2026

One of the challenges in stroke prevention has been tips on how to handle sufferers with considerably narrowed carotid arteries who haven’t had a current stroke or transient ischemic assault. Whether, when and tips on how to intervene in these sufferers has been a topic of debate for a very long time. Their threat is decrease however not negligible, and the big variety of such sufferers signifies that even small enhancements in prevention methods can have a big effect.

The CREST-2 trial—published in The New England Journal of Medicine—is a brand new research that might change how asymptomatic sufferers at severe threat for stroke are handled and, hopefully, assist them keep away from having a stroke in any respect. The research targeted on individuals with extreme blockages of their carotid arteries. With about 800,000 strokes within the U.S. yearly, these blockages account for over 130,000 of them. 

“Research conducted decades ago determined that a combination of revascularization procedures, medications and lifestyle changes was beneficial,” mentioned research coauthor Herbert Aronow, MD, MPH, an interventional heart specialist and medical director of Heart and Vascular Services at Henry Ford Health. “However, this research was conducted in an era when medical therapy was not as advanced as it is today, with far fewer medications available to reduce stroke risk.”

“With more effective medical therapies available now, we questioned whether conclusions drawn decades ago are still valid today,” mentioned Dr. Aronow. “Specifically, is it still appropriate to subject asymptomatic patients to an invasive procedure for a carotid artery blockage?”

Given that thousands and thousands of persons are unaware of their threat stage, and that every one too typically the primary warning signal could be a life-threatening stroke, the research’s discovering {that a} minimally invasive process can right the blockage and keep away from stroke might enhance outlooks and outcomes for many individuals.

Henry Ford Health is a part of the AMA Health System Member Program, which gives enterprise options to equip management, physicians and care groups with assets to assist drive the way forward for medication.

Answering a long-standing query

The research concerned greater than 1,200 sufferers in 155 well being facilities in 5 nations. Participants have been adopted for 4 years, and plans are to observe them out to 10 years. This is essential given the comparatively low annual occasion charges in asymptomatic sufferers and the next want for prolonged commentary.

CREST-2 included two separate randomized trials evaluating treatment and way of life adjustments alone versus mixed with carotid revascularization. The first employed carotid endarterectomy, the long-time normal observe for repairing a narrowed carotid artery. The second utilized carotid stenting, which makes use of a catheter to position a small wire mesh tube contained in the artery to prop it open. Results of each trials have been then in contrast with remedy by treatment and way of life adjustments alone.

“Long ago, carotid endarterectomy became the gold standard,” Dr. Aronow defined. “When carotid stenting emerged a couple of decades ago, it was compared to endarterectomy and found to be equivalent for most patients. However, it had never been tested directly against medical therapy and lifestyle change alone.”

In the trial, sufferers who underwent stenting, mixed with treatment and way of life adjustments, have been subsequently at much less threat of stroke than these handled with noninvasive administration alone. The threat of stroke within the stenting cohort was lowered by about half over 4 years, the primary direct, randomized proof of stenting’s extra advantages above and past medical remedy.

On the surgical facet, outcomes have been directionally comparable however didn’t attain statistical significance at 4 years. Longer follow-up is predicted to supply extra info as extra occasions happen.

Challenging expectations

The findings point out a number of key takeaways in the case of stopping stroke.

Carotid artery illness is without doubt one of the few cardiovascular circumstances through which treating sufferers with out signs could also be acceptable. This is rare in heart problems, as most asymptomatic circumstances are managed conservatively. CREST-2 reinforces that carotid artery illness represents a definite exception in rigorously chosen sufferers. Also, it highlights that a number of remedy choices may be secure and simpler than medical administration alone.

“However,” Dr. Aronow cautioned, “these procedures do not replace medical therapy but complement ongoing management of risk factors.”

The launch of the CREST-2 outcomes has sparked energetic dialogue inside the medical neighborhood. Many have been shocked by the findings, having anticipated that advances in medical remedy alone would remove the necessity for procedural intervention. 

“We sometimes struggle as a community to take a fresh, objective look at new data. Some clinicians have been inclined to overinterpret the results as favoring one procedural approach over another, while others have focused on perceived limitations of the study design,” Dr. Aronow mentioned. “But the trial was not designed to compare carotid stenting directly with surgery. 

“Rather, it addressed a more fundamental question: Does intervening on asymptomatic carotid stenosis still provide benefits in the era of modern medical therapy?” he added.

What this implies for asymptomatic sufferers

The outcomes of the research present that even with in the present day’s superior drugs and methods for controlling threat components, procedural intervention can considerably cut back the chance of stroke in lots of asymptomatic sufferers. This challenges the belief that medical administration by itself can be ample for all such sufferers.

“Carotid stenosis should not be viewed as an isolated condition,” mentioned Dr. Aronow. “It is one manifestation of atherosclerotic cardiovascular disease, a systemic process involving plaque buildup throughout the arterial system.”

When carotid illness is recognized, comparable pathology is commonly current in coronary arteries or peripheral circulation, even when it has not but produced signs elsewhere. While sure threat components can’t be mitigated, similar to age, others like blood stress, ldl cholesterol, smoking and diabetes may be modified. Given that about half of adults within the U.S. have hypertension, and most wouldn’t have it managed in accordance with present pointers, major care can play a key function in figuring out and decreasing these dangers.

Atherosclerosis typically begins a long time earlier than it turns into clinically obvious, with post-mortem research revealing early plaque formation in even younger adults. This underscores the significance of addressing modifiable threat components early, properly earlier than carotid illness or neurologic signs develop.

Prevention begins with medical administration

Risk issue modification was a central part of the trial. While way of life modification proved critically essential, the research confirmed that it’s typically inadequate by itself for high-risk sufferers. Medications are nonetheless mandatory to attain guideline-recommended targets, notably for ldl cholesterol administration, as a result of way of life adjustments alone can’t adequately cut back ranges which can be considerably above goal.

Carotid stenting as an choice provides to the significance of discussing all accessible programs of remedy with sufferers. Even although all choices are secure and efficient, they could not align with particular person sufferers’ preferences. Some might need to keep away from invasive procedures, whereas others could also be uncomfortable with long-term treatment use, and these preferences ought to be revered and thought of when planning for care.

“Shared decision-making needs to be part of everything we do,” Dr. Aronow mentioned. “Our responsibility is to work with patients to help them achieve their health goals in ways that are meaningful to them.”


This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://www.ama-assn.org/public-health/chronic-diseases/rethinking-stroke-prevention-asymptomatic-carotid-disease
and if you wish to take away this text from our web site please contact us